The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic portfolio management to optimize resource allocation and enhance competitive advantage.
Mehtap Saydam Aydemir
Advertisement
Articles by Mehtap Saydam Aydemir
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
2
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
3
FDA Approves Wegovy HD Injectable Under Accelerated Approval
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5